Standard Biotools (LAB) Operating Expenses (2010 - 2026)

Standard Biotools (LAB) has 17 years of Operating Expenses data on file, last reported at $23.8 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $23.8 million, down 37.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.6 million (down 10.55% YoY), and the FY2025 annual result was $152.8 million, down 11.36% from the prior year.
• Operating Expenses eased to $23.8 million in Q1 2026 per LAB's latest filing, from $36.0 million in the prior quarter.
• Over five years, Operating Expenses peaked at $84.4 million in Q1 2024 and troughed at $23.8 million in Q1 2026.
• A 5-year average of $39.6 million and a median of $37.4 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 192.2% in 2024, then sank 54.94% in 2025.
• A 5-year view of Operating Expenses shows it stood at $32.3 million in 2022, then climbed by 7.63% to $34.7 million in 2023, then grew by 7.76% to $37.4 million in 2024, then decreased by 3.77% to $36.0 million in 2025, then tumbled by 33.93% to $23.8 million in 2026.
• Business Quant data shows LAB's Operating Expenses at $23.8 million in Q1 2026, $36.0 million in Q4 2025, and $42.4 million in Q3 2025.